Novus Therapeutics (NVUS) Releases Earnings Results, Misses Expectations By $0.09 EPS - Fairfield Current

Novus Therapeutics (NVUS) Releases Earnings Results, Misses Expectations By $0.09 EPS  Fairfield Current

Novus Therapeutics (NASDAQ:NVUS) issued its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.49) earnings per share ...



Comments

Popular posts from this blog

Summary of Society for Maternal-Fetal Medicine (SMFM) Consult Series #52: Diagnosis and management of fetal growth restriction - Contemporary Obgyn

BTS Clinical Statement on air travel for passengers with respiratory disease - Thorax (BMJ)